COMPUTATIONAL BIOLOGY AND CHEMISTRY
Scope & Guideline
Empowering Researchers to Navigate the Frontiers of Computational Biology and Chemistry
Introduction
Aims and Scopes
- Computational Drug Design:
Research in this area emphasizes the use of computational methods for the design and optimization of small molecules and biologics, particularly in drug discovery and development. - Bioinformatics and Genomics:
This scope covers the application of computational tools to analyze biological data, including genomic sequences, transcriptomic data, and proteomics, facilitating the identification of biomarkers and therapeutic targets. - Molecular Dynamics and Simulations:
The journal publishes studies that utilize molecular dynamics simulations to understand the behavior of biomolecules and their interactions, providing insights into mechanisms of action and stability. - Machine Learning and AI in Biology:
The integration of machine learning and artificial intelligence techniques into biological research to enhance predictive modeling, classification, and data analysis is a prominent focus. - Systems Biology and Network Analysis:
Research that explores biological systems through the lens of network theory, including the interactions between genes, proteins, and metabolites, is a core area of interest. - Structural Bioinformatics:
Studies that involve the computational analysis of protein structures, interactions, and dynamics to elucidate functional mechanisms and design inhibitors.
Trending and Emerging
- Integrative Omics Approaches:
Recent publications highlight the trend of using multi-omics data integration (genomics, proteomics, metabolomics) to uncover complex biological insights and therapeutic targets. - Deep Learning Applications:
There is a significant increase in the use of deep learning techniques for various applications, including protein structure prediction, drug discovery, and biomarker identification. - Network Pharmacology:
The field of network pharmacology is gaining traction, with studies focusing on understanding the interactions between drugs and biological networks, enabling more holistic drug development strategies. - Artificial Intelligence in Drug Repurposing:
The use of AI to identify existing drugs for new therapeutic applications is increasingly prevalent, reflecting a shift towards more efficient drug development processes. - Computational Metabolomics:
Emerging research in computational metabolomics is gaining attention, focusing on the analysis of metabolic pathways and their implications in health and disease. - Structural Bioinformatics with AI:
A growing trend is the application of AI to assist in structural bioinformatics, particularly in predicting protein-ligand interactions and understanding protein folding.
Declining or Waning
- Traditional QSAR Studies:
Quantitative Structure-Activity Relationship (QSAR) studies, once a staple in computational chemistry, have seen reduced emphasis as more advanced machine learning techniques gain popularity for predictive modeling. - Single-Method Approaches:
There is a noticeable decline in publications focusing solely on one computational method, as interdisciplinary approaches combining multiple methodologies are becoming preferred. - Basic Molecular Docking Studies:
Basic studies on molecular docking without incorporating advanced techniques or extensive validation have become less prevalent, as the field moves towards more integrated and robust computational frameworks. - In Vitro Validation Studies:
While still relevant, the frequency of papers that solely focus on in vitro validation of computational predictions without substantial computational contributions has decreased.
Similar Journals
Interdisciplinary Sciences-Computational Life Sciences
Advancing Life Sciences Through Computational InnovationInterdisciplinary Sciences-Computational Life Sciences, published by SPRINGER HEIDELBERG, is a premier journal dedicated to advancing the field of life sciences through the lens of computational methods. With an ISSN of 1913-2751 and an E-ISSN of 1867-1462, this journal serves as a significant platform for researchers and professionals alike, fostering innovation and collaboration across various disciplines. As a testament to its impact, the journal holds a Q2 category status in Biochemistry, Genetics and Molecular Biology, Computer Science Applications, and Health Informatics, reflecting its influential contributions and rigorous peer-review process. The Scopus rankings demonstrate its esteemed placement within its fields, with notable percentiles that highlight its relevance and reach. While the journal operates under a traditional access model, its commitment to publishing high-quality research continues to stimulate important discussions and developments within the scientific community. Founded in 2009 and converging through 2024, Interdisciplinary Sciences-Computational Life Sciences remains an essential resource for the latest discoveries at the intersection of computation and life sciences, appealing to both seasoned researchers and enthusiastic students eager to contribute to this dynamic field.
Bioinformatics Advances
Innovative Insights for Computational BiologyBioinformatics Advances, published by Oxford University Press, is an esteemed academic journal that serves as a vital platform for the dissemination of innovative research in the rapidly evolving fields of bioinformatics and computational biology. With a promising E-ISSN of 2635-0041, this journal has made significant strides since its inception in 2021, achieving a commendable Q1 ranking in both the Computer Science Applications and Genetics categories, alongside respectable Q2 rankings in Molecular Biology and Structural Biology as of 2023. Though currently not an open-access publication, its critical insights cater to an audience keen on advancing knowledge and technology in genomic studies and data analytics. The journal emphasizes high-quality research and aims to facilitate the integration of computational techniques within biological sciences, making it an essential resource for researchers, professionals, and students alike who seek to stay at the forefront of bioinformatics advancements.
Quantitative Biology
Harnessing Mathematical Models to Illuminate Biological PhenomenaQuantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.
Molecular Informatics
Bridging Computational Techniques with Biological InnovationMolecular Informatics is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to advancing the fields of computational analysis and molecular modeling. As a key resource in the realms of Computer Science Applications, Drug Discovery, Molecular Medicine, Organic Chemistry, and Structural Biology, this journal is recognized for its significant contributions and is ranked in the Q2 and Q3 categories across multiple disciplines, positioning it among the leading journals for researchers and academics. With an impressive track record since its inception in 2010 and converging its contributions until 2024, Molecular Informatics aims to bridge the gap between computational techniques and biological applications, promoting interdisciplinary collaboration and innovation. Accessible to a global audience, the journal reflects a commitment to advancing science through open access options, making cutting-edge research available to students, professionals, and decision-makers alike. This journal serves as an indispensable platform for disseminating high-quality research and fostering the development of new theoretical and practical frameworks in molecular informatics.
BIOINFORMATICS
Pioneering Insights in Biochemistry and Computational ScienceBIOINFORMATICS, published by Oxford University Press, is a leading journal in the realms of biochemistry, computational mathematics, and computer science, with a notable impact factor that underscores its significance in the field. Since its inception in 1985 and continuing through its expected convergence in 2024, the journal has maintained a prestigious reputation, proudly residing in the Q1 category across multiple disciplines, including molecular biology and statistics. With a Scopus ranking placing it within the top percentiles of its categories, BIOINFORMATICS serves as an essential platform for disseminating high-quality research that advances knowledge and innovation at the intersection of biology and computational sciences. This journal not only offers both subscription and open access options, ensuring wider availability of its cutting-edge research, but it has also become a crucial resource for researchers, professionals, and students aiming to stay at the forefront of bioinformatics and related fields. Explore the latest findings and trends that define the future of biological research through this esteemed publication, any inquiries regarding the journal can be directed to its offices located at Great Clarendon St, Oxford OX2 6DP, England.
IEEE-ACM Transactions on Computational Biology and Bioinformatics
Unlocking Complex Biological Systems Through InnovationIEEE-ACM Transactions on Computational Biology and Bioinformatics is a prestigious journal published by the IEEE Computer Society, focusing on the interdisciplinary field of computational biology and bioinformatics. Established in 2004, this journal has made significant strides in contributing to our understanding of complex biological systems through quantitative methods and computational techniques, and it spans a converged publication period through 2024. As a notable resource with an impact factor that positions it in the second quartile in the domains of Applied Mathematics, Biotechnology, and Genetics, it serves as an essential platform for researchers and professionals seeking to disseminate their findings to a global audience. The journal ranks impressively in Scopus, with Applied Mathematics holding a rank of #38 out of 635 (94th percentile) and Genetics at #86 out of 347 (75th percentile), highlighting its significant influence in the scientific community. While the journal is not open-access, it provides valuable insights and cutting-edge research that are crucial for advancing the fields of bioinformatics and computational biology, making it indispensable for students, researchers, and practitioners alike.
JOURNAL OF COMPUTATIONAL BIOLOGY
Innovating Insights at the Intersection of Biology and TechnologyJOURNAL OF COMPUTATIONAL BIOLOGY, published by Mary Ann Liebert, Inc., serves as a premier platform for the dissemination of groundbreaking research at the intersection of biological sciences and computational methods. Established in 1994, this journal provides a valuable resource for researchers, professionals, and students interested in the evolving fields of computational mathematics and biology. With a commendable Q2 ranking in several pertinent categories such as Computational Mathematics and Modeling and Simulation, it emphasizes high-quality studies that propel understanding and innovation in these areas. Although the journal currently operates under traditional access options, it plays a crucial role in fostering scholarly communication and collaboration among a diverse audience, advancing knowledge in genetics, molecular biology, and beyond. The journal's continual evolution, with a commitment to publish until at least 2024, positions it as a critical resource in the fast-paced world of computational biology.
COMPUTERS IN BIOLOGY AND MEDICINE
Elevating Medical Insights with Computational ExcellenceCOMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.
Current Bioinformatics
Transforming Biological Data into Meaningful KnowledgeCurrent Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.
BioData Mining
Advancing Knowledge at the Intersection of Biology and TechnologyBioData Mining is a distinguished open access journal published by BMC, focusing on the dynamic intersection of bioinformatics, computational mathematics, and molecular biology. Since its inception in 2008, this journal has provided a critical platform for researchers and professionals to publish their findings, contributing significantly to the collective knowledge in fields such as biochemistry, computational theory, and genetics. With a robust impact factor and a commendable h-index, BioData Mining continues to be a vital resource for academic and industrial advancements, ranked in the top quartiles in various categories according to the 2023 metrics. The journal's commitment to open access ensures that cutting-edge research is readily available to the global scientific community, thereby enhancing visibility and fostering collaboration among scholars. Whether you are a researcher, student, or practitioner, engaging with BioData Mining will equip you with relevant insights and developments in the fast-evolving realm of bioinformatics.